Skip to main content
logo
Seaport Therapeutics, Inc. (SPTX)
NASDAQ: SPTX · Real-Time Price · USD
20.01
+0.41 (2.09%)
At close: Nov 2, 2026, 4:00 PM EST
20.01
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:33 PM EST

Seaport Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash & Equivalents
-46.04309.1
Short-Term Investments
-169.94-
Cash & Short-Term Investments
273.31215.98309.1
Cash Growth
--30.13%-
Other Receivables
-3.03-
Receivables
-3.03-
Prepaid Expenses
-1.180.39
Other Current Assets
-3.040.66
Total Current Assets
-223.23310.15
Property, Plant & Equipment
-5.235.17
Long-Term Investments
-17.67-
Long-Term Deferred Charges
-1.2-
Other Long-Term Assets
-1.680.45
Total Assets
-249.01315.78

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Accounts Payable
-2.014.73
Accrued Expenses
-9.135.21
Current Portion of Leases
-1.640.86
Other Current Liabilities
-0.010.35
Total Current Liabilities
-12.7811.15
Long-Term Leases
-3.444.15
Total Liabilities
-16.2315.3

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Common Stock
-00
Additional Paid-In Capital
-21.2614.38
Retained Earnings
--114.11-39.23
Comprehensive Income & Other
-0.3-
Total Common Equity
422.6-92.55-24.85
Shareholders' Equity
422.6232.78300.48
Total Liabilities & Equity
-249.01315.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Total Debt
5.025.085.01
Net Cash (Debt)
268.29210.9304.09
Net Cash Growth
--30.65%-
Net Cash Per Share
9.3428.29102.68
Filing Date Shares Outstanding
53.538.158.15
Total Common Shares Outstanding
53.538.158.15
Working Capital
-210.45299
Book Value Per Share
7.89-11.35-3.05
Tangible Book Value
422.6-92.55-24.85
Tangible Book Value Per Share
7.89-11.35-3.05
Machinery
-0.970.98
Leasehold Improvements
-0.430.1
SEC Filings: 10-K · 10-Q